A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
- Sponsor
- Charite University, Berlin, Germany
- Study ID
- NCT00168896
- Phase
- PHASE2/PHASE3
- Status
- Unknown
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
Study Details
Comparison of two combination chemotherapies in the treatment of patients with SLCL
Key Dates
- Start date
- Oct 31, 2001
- Status verified
- Sep 2001
- Completion
- Dec 31, 2006
Study Design
- Enrollment
- 286 participants
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Primary Outcome Measure
Primary Endpoint:
Central Contacts
- Ulrich Keilholz, MD+49-30-8445-3596
- Alexander Schmittel, MD+49-30-8445-3090alexander.schmittel @charite.de
Related Studies
- Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial TumorsRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56PHASE1/PHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California
- TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)Recruiting · Tempus AI · Los Alamitos, California